Fortis Healthcare Ltd

Fortis Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fortis Healthcare Ltd

₹ 932 -0.35%
07 Aug 11:57 a.m.
fortishealthcare.com BSE: 532843 NSE: FORTIS
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Business Segments [1]
a) Hospital Segment: Co. operates Multi-specialty and super-specialty hospitals providing inpatient and outpatient treatments across various disciplines.

Website BSE NSE
  • Market Cap ₹ 70,340 Cr.
  • Current Price ₹ 932
  • High / Low ₹ 1,105 / 767
  • Stock P/E 352
  • Book Value ₹ 122
  • Dividend Yield 0.11 %
  • ROCE 3.96 %
  • ROE 2.13 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 51.4% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 63.0%

Cons

  • Stock is trading at 7.61 times its book value
  • Company has a low return on equity of 1.64% over last 3 years.
  • Earnings include an other income of Rs.172 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
289 294 291 307 333 357 367 388 433 456 443 461 489
254 255 242 238 275 297 300 318 345 356 344 350 386
Operating Profit 35 40 49 69 58 60 67 71 88 100 99 110 104
OPM % 12% 13% 17% 23% 17% 17% 18% 18% 20% 22% 22% 24% 21%
31 110 32 65 35 36 40 -27 57 114 21 4 32
Interest 23 21 19 18 17 16 27 52 52 51 56 48 47
Depreciation 25 25 25 26 26 27 29 31 30 28 30 30 30
Profit before tax 18 104 36 90 50 52 51 -39 63 135 34 37 59
Tax % 27% 8% 36% 24% 47% 24% 22% 9% 18% 7% 17% 33% 19%
13 95 23 68 27 40 40 -42 52 125 28 25 48
EPS in Rs 0.17 1.26 0.30 0.91 0.36 0.52 0.52 -0.56 0.69 1.66 0.38 0.33 0.63
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
611 612 645 659 656 702 633 863 1,053 1,181 1,446 1,792 1,849
758 737 792 697 780 633 605 747 919 988 1,190 1,395 1,436
Operating Profit -148 -125 -146 -38 -123 69 28 116 134 193 256 397 413
OPM % -24% -20% -23% -6% -19% 10% 4.4% 13% 13% 16% 18% 22% 22%
220 166 165 70 522 809 248 118 197 236 83 196 172
Interest 81 65 106 64 192 160 141 130 106 82 112 206 201
Depreciation 27 25 27 29 27 97 111 113 116 101 113 118 118
Profit before tax -36 -50 -114 -60 180 621 24 -9 109 247 114 270 266
Tax % -5% -19% -34% 6% 31% 17% 83% 48% 12% 19% 44% 15%
-34 -40 -75 -64 123 513 4 -13 96 199 64 230 226
EPS in Rs -0.73 -0.87 -1.44 -1.23 1.63 6.80 0.06 -0.18 1.27 2.64 0.84 3.05 3.00
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 78% 38% 118% 33%
Compounded Sales Growth
10 Years: 11%
5 Years: 23%
3 Years: 19%
TTM: 20%
Compounded Profit Growth
10 Years: 25%
5 Years: 51%
3 Years: 53%
TTM: 14%
Stock Price CAGR
10 Years: 17%
5 Years: 30%
3 Years: 41%
1 Year: 4%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 2%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 463 463 518 519 755 755 755 755 755 755 755 755
Reserves 3,217 3,284 3,754 3,708 7,608 8,122 8,127 8,114 8,209 8,332 8,319 8,474
1,234 1,076 647 555 1,478 1,361 1,380 1,193 785 659 2,039 2,078
246 215 242 234 279 343 320 365 620 640 887 688
Total Liabilities 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 11,999 11,994
190 172 186 203 180 906 853 770 492 467 925 1,266
CWIP 169 182 199 166 165 33 7 6 3 260 42 95
Investments 2,411 2,428 3,603 3,658 8,310 8,153 8,898 8,845 8,848 8,834 10,178 10,071
2,389 2,257 1,174 989 1,466 1,489 824 804 1,027 825 853 562
Total Assets 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 11,999 11,994

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-144 -761 22 -15 -61 100 32 76 198 218 334 116
294 394 -72 245 -4,688 810 28 238 205 44 -1,572 11
-170 370 45 -292 4,792 -972 6 -320 -395 -245 1,276 -176
Net Cash Flow -20 3 -5 -62 43 -62 66 -6 8 18 38 -49
Free Cash Flow -212 -761 -35 -60 -66 86 -23 50 145 44 -31 -190
CFO/OP 77% 594% 13% 46% 8% 161% 148% 108% 173% 125% 130% 56%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 57 61 43 39 47 42 37 32 34 41 46 49
Inventory Days 18 15 14 19 17 25 21 25 18 15 16 18
Days Payable 240 289 340 392 542 525 520 494 572 608 643 399
Cash Conversion Cycle -165 -213 -284 -334 -479 -457 -462 -438 -520 -553 -581 -332
Working Capital Days 354 -168 -206 -130 -594 -59 -52 -25 -24 -74 -165 -139
ROCE % 0% 1% -0% 1% 5% 9% 1% 1% 2% 2% 3% 4%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Diagnostic Tests Volume (Agilus)
Mn tests

Log in to view insights

Please log in to see hidden values.

Login
International Patient Revenue Share (Hospital Business)
%
ALOS (Average Length of Stay)
Days
ARPOB (Average Revenue Per Occupied Bed)
INR Cr p.a.
Customer Touchpoints (CTPs) - Agilus Diagnostics
Count
Healthcare Facilities (Hospitals)
Count
Hospital Occupancy
%
Operational Beds (Hospitals, incl. O&M)
Beds

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
26.31% 23.72% 23.24% 23.31% 25.26% 26.77% 27.40% 27.18% 27.90% 27.84% 25.98% 25.20%
26.55% 29.42% 31.14% 32.31% 30.73% 30.05% 29.46% 29.79% 29.14% 29.33% 31.35% 32.23%
15.97% 15.71% 14.44% 13.22% 12.83% 12.02% 11.98% 11.87% 11.79% 11.65% 11.50% 11.40%
No. of Shareholders 1,31,5161,35,6641,57,1651,54,2602,04,1842,21,7502,18,3292,05,3732,20,7662,33,1562,26,6852,20,743

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls